Scott Waddell


I graduated from the University of Glasgow in 2016 with a Bachelor of Science (with First Class Honours) degree in Biochemistry and the University of Edinburgh in 2017 with a Masters of Science in Drug Discovery & Translational Biology. Throughout both these degrees, I developed a strong interest in the molecular mechanisms that drive and the development of therapeutic targets that treat human diseases.

In 2017, I joined the Institute of Genetics & Cancer (IGC, previously Institute of Genetics & Molecular Medicine) on the MRC Human Genetics Unit 4 year PhD programme. I undertook rotational projects studying chromatin dynamics on genome editing (with Dr Andrew Wood) and computational protein biology (with Dr Joe Marsh), and ultimately chose to work alongside Dr Pleasantine Mill & Dr Luke Boulter to understand the role primary cilia play in liver homeostasis and disease. My PhD project focused on understanding the cell and molecular mechanisms underpinning polycystic liver disease after the loss of the cholangiocyte primary cilium.

In 2022, I was awarded an Early Postdoctoral Fellowship from the Chief Scientist Office (Scottish Government) to undertake a 3 year project to understand the role of inflammation in polycystic liver disease.


  • PhD Genetics & Molecular Medicine, The University of Edinburgh, 2017-2022
  • MSc Drug Discovery & Translational Biology, The University of Edinburgh, 2016-2017
  • BSc (Hons) Biochemistry, University of Glasgow, 2012-2016

Project activity

Defining how primary cilia loss drives inflammation in polycystic liver disease

Current project grants

CSO Early Postdoctoral Fellowship (2022-2025)

View all 5 publications on Research Explorer